Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrahams, S.
Right arrow Articles by Goldstein, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrahams, S.
Right arrow Articles by Goldstein, L. H.
Related Collections
Right arrow Amyotrophic lateral sclerosis
Right arrow All Cognitive Disorders/Dementia
Right arrow Frontotemporal dementia
NEUROLOGY 2005;64:1222-1226
© 2005 American Academy of Neurology

Cognitive change in ALS

A prospective study

S. Abrahams, DClinPsy, PhD, P. N. Leigh, PhD and L. H. Goldstein, PhD

From Department of Psychology (Dr. Abrahams), School of Philosophy, Psychology and Language Sciences, The University of Edinburgh; and Department of Psychology (Dr. Goldstein), Department of Neurology (Dr. Leigh), Institute of Psychiatry, King’s College London, UK.

Address correspondence and reprint requests to Dr. Sharon Abrahams, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK.

Objectives: To investigate longitudinally the profile of cognitive impairment in nondemented patients with ALS.

Methods: Twenty nondemented patients with ALS and 18 controls were interviewed at two time points separated by a 6-month interval. The extensive battery was designed to accommodate the range of physical disability present in ALS, and included measures of executive, memory, language, and visuospatial functions, everyday behavior, and emotion.

Results: On a test of simple word retrieval (Computerised Sentence Completion Test) patients with ALS became slower over time, while controls became faster at completing sentences with appropriate words. This effect remained when the analysis accommodated for progressive speech disability. Patients with ALS also displayed an impairment in both written and spoken verbal fluency indices (time to think of each word) at both time points, but there was no evidence of deterioration over time. On the Short Inventory of Minor Lapses, carers of patients with ALS displayed increased awareness of cognitive dysfunction in everyday behavior while controls’ ratings of their partners decreased. In addition, patients displayed more depressive symptomology (although well below clinical levels) on the second interview vs controls. Patients with ALS also displayed emotional lability at both time points, although this did not increase over time.

Conclusions: Cognitive deterioration in nondemented patients with ALS is a relatively slow process. Selective cognitive impairment in the form of verbal fluency deficits, most likely indicating executive dysfunction, appears relatively early on in the course of the disease, although language functions may become vulnerable as the disease progresses.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the April 12 issue to find the title link for this article.

This project was funded by the Wellcome Trust and S.A. was funded by a Wellcome Trust Fellowship throughout the period of research. The King’s MND Care and Research Centre is funded by the Motor Neuron Disease Association, UK.

Received September 1, 2004. Accepted in final form December 27, 2004.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Lakerveld, B Kotchoubey, and A Kubler
Cognitive function in patients with late stage amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 25 - 29.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. W. Wheaton, A. R. Salamone, D. M. Mosnik, R. O. McDonald, S. H. Appel, H. I. Schmolck, G. M. Ringholz, and P. E. Schulz
Cognitive impairment in familial ALS
Neurology, October 2, 2007; 69(14): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
D. Irwin, C. F. Lippa, and J.M. Swearer
Cognition and Amyotrophic Lateral Sclerosis (ALS)
American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 300 - 312.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Murphy, R. Henry, and C. Lomen-Hoerth
Establishing Subtypes of the Continuum of Frontal Lobe Impairment in Amyotrophic Lateral Sclerosis
Arch Neurol, March 1, 2007; 64(3): 330 - 334.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. H. Goldstein, L. Atkins, S. Landau, R. G. Brown, and P. N. Leigh
Longitudinal predictors of psychological distress and self-esteem in people with ALS.
Neurology, November 14, 2006; 67(9): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Morita, A. Al-Chalabi, P. M. Andersen, B. Hosler, P. Sapp, E. Englund, J. E. Mitchell, J. J. Habgood, J. de Belleroche, J. Xi, et al.
A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia
Neurology, March 28, 2006; 66(6): 839 - 844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.